Inventor · disambiguated record
Lex M. Cowsert
Also filed as: COWSERT LEX M
143 granted patents·74 pending applications·6,830 citations·filing 1991–2014
99Inventor score
Top patents by PatentIndex Score
217 records- 0199US7745609B2Antisense modulation of CD40 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Jun 29, 2010·189 cites·46 claims
- 0299US6566131B1Antisense modulation of Smad6 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted May 20, 2003·366 cites·27 claims
- 0399US6426220B1Antisense modulation of calreticulin expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 30, 2002·228 cites·26 claims
- 0498US6303374B1Antisense modulation of caspase 3 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Oct 16, 2001·219 cites·4 claims
- 0598US6107091AAntisense inhibition of G-alpha-16 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Aug 22, 2000·388 cites·24 claims
- 0698US6046321AAntisense modulation of G-alpha-i1 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 4, 2000·372 cites·22 claims
- 0798US5981732AAntisense modulation of G-alpha-13 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Nov 9, 1999·370 cites·24 claims
- 0896US6261840B1Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 17, 2001·98 cites·15 claims
- 0996US6258601B1Antisense modulation of ubiquitin protein ligase expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 10, 2001·75 cites·16 claims
- 1096US6033910AAntisense inhibition of MAP kinase kinase 6 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Mar 7, 2000·176 cites·20 claims
- 1196US6025198AAntisense modulation of Ship-2 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Feb 15, 2000·107 cites·15 claims
- 1296US5998206AAntisense inhibiton of human G-alpha-12 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 7, 1999·203 cites·10 claims
- 1396US5958773AAntisense modulation of AKT-1 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Sep 28, 1999·202 cites·12 claims
- 1496US5580767AInhibition of influenza viruses by antisense oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1991·Granted Dec 3, 1996·158 cites·4 claims
- 1595US7563884B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 21, 2009·67 cites·28 claims
- 1695US7321828B2System of components for preparing oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 22, 2008·216 cites·4 claims
- 1795US6410323B1Antisense modulation of human Rho family gene expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Jun 25, 2002·384 cites·13 claims
- 1895US6335194B1Antisense modulation of survivin expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jan 1, 2002·69 cites·23 claims
- 1995US5457189AAntisense oligonucleotide inhibition of papillomavirusISIS PHARMACEUTICALS INC·Filed 1992·Granted Oct 10, 1995·224 cites·1 claims
- 2093US6159697AAntisense modulation of Smad7 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 12, 2000·49 cites·10 claims
- 2193US6100090AAntisense inhibition of PI3K p85 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Aug 8, 2000·137 cites·21 claims
- 2293US5985663AAntisense inhibition of interleukin-15 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Nov 16, 1999·117 cites·19 claims
- 2392US6284538B1Antisense inhibition of PTEN expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 4, 2001·38 cites·32 claims
- 2492US6277640B1Antisense modulation of Her-3 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 21, 2001·32 cites·11 claims
- 2592US6184212B1Antisense modulation of human mdm2 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·78 cites·20 claims
- 2691US6838283B2Antisense modulation of survivin expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jan 4, 2005·27 cites·9 claims
- 2791US6046049AAntisense modulation of PI3 kinase p110 delta expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 4, 2000·88 cites·25 claims
- 2891US6007995AAntisense inhibition of TNFR1 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 28, 1999·88 cites·11 claims
- 2990US6613567B1Antisense inhibition of Her-2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 2, 2003·22 cites·15 claims
- 3090US6451602B1Antisense modulation of PARP expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 17, 2002·35 cites·26 claims
- 3190US5945290AAntisense modulation of RhoA expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Aug 31, 1999·91 cites·12 claims
- 3289US7288530B2Antisense modulation of survivin expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Oct 30, 2007·14 cites·30 claims
- 3389US6784290B1Antisense oligonucleotide inhibition of rasISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 31, 2004·19 cites·15 claims
- 3489US6013522AAntisense inhibition of human Smad1 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Jan 11, 2000·86 cites·20 claims
- 3588US6602857B1Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 5, 2003·32 cites·72 claims
- 3688US6352858B1Antisense modulation of BTAK expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Mar 5, 2002·16 cites·13 claims
- 3787US6372492B1Antisense modulation of talin expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 16, 2002·13 cites·26 claims
- 3887US6346416B1Antisense inhibition of HPK/GCK-like kinase expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 12, 2002·19 cites·26 claims
- 3987US6069008AAntisense modulation of NF-kappa-B p65 subunit expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted May 30, 2000·56 cites·10 claims
- 4086US5951455AAntisense modulation of G-alpha-11 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Sep 14, 1999·65 cites·12 claims
- 4185US6743909B2Antisense modulation of PTPN12 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 1, 2004·9 cites·12 claims
- 4285US6294382B1Antisense modulation of SRC-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 25, 2001·11 cites·26 claims
- 4385US6066500AAntisense modulation of Beta catenin expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted May 23, 2000·61 cites·20 claims
- 4484US8017760B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·4 cites·13 claims
- 4584US7179796B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Feb 20, 2007·12 cites·3 claims
- 4684US6482644B1Antisense modulation of dual specific phosphatase 8 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 19, 2002·10 cites·26 claims
- 4784US6383809B1Antisense inhibition of cytohesin-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted May 7, 2002·11 cites·26 claims
- 4884US6242590B1Antisense modulation of zinc finger protein-217 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jun 5, 2001·10 cites·13 claims
- 4984US6197584B1Antisense modulation of CD40 expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Mar 6, 2001·59 cites·19 claims
- 5083US6187545B1Antisense modulation of pepck-cytosolic expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·17 cites·10 claims
Showing the top 50 of 217 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lex M. Cowsert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →